Skip to main content

Table 4 Clinical characteristics according to category of body mass index (BMI)

From: High prevalence of obesity in rheumatoid arthritis patients: association with disease activity, hypertension, dyslipidemia and diabetes, a multi-center study

Variable Low weight or eutrophic n = 274 (100%) Overweight n = 295 (100%) Obese
n = 209 (100%)
Total
n = 788
(100%)
p-value
Female sex (n; %) 236 (86.1) 254 (86.1) 185 (88.5) 675 (85.6) 0.467
Non-white race/color (n; %) 103 (37.6) 120 (40.7) 83 (39.7) 462 (58.6) 0.554
Age (mean ± SD) 53.5 ± 13.3 54.6 ± 12.1 56.6 ± 9.9 57.0 ± 12.0 0.037
Disease duration (mean ± SD) 13.4 ± 9.6 12.9 ± 8.6 12.3 ± 8.3 12.9 ± 8.9 0.389
Diabetes mellitus (n; %) 36 (13.1) 44 (14.9) 37 (17.7) 117 (14.8) 0.168
Systemic arterial hypertension (n; %) 117 (42.7) 128 (43.4) 139 (66.5) 384 (48.7) < 0.001
Dyslipidemia (n; %) 70 (25.5) 98 (33.2) 92 (44.0) 260 (32.9) < 0.001
Family history of CVD (n; %) 41 (14.9) 50 (16.9) 37 (17.7) 128 (16.2) 0.379
Smoking (n; %) 35 (12.8) 36 (12.2) 21 (10.0) 92 (11.7) 0.319
Use of methotrexate (n; %) 189 (68.9) 196 (66.4) 137 (65.5) 522 (66.2) 0.558
Use of prednisone (n; %) 162 (59.1) 188 (63.7) 131 (62.7) 481 (61.0) 0.342
Use of leflunomide (n; %) 94 (34.3) 104 (35.2) 73 (34.9) 271 (34.3) 0.972
C-reactive protein (mean ± SD) 18.7 ± 59.0 14.7 ± 36.2 31.0 ± 138.9 20.4 ± 82.3 0.137
Rheumatoid factor (n; %) 187 (68.2) 192 (65.1) 144 (68.9) 523 (66.4) 0.762
DAS28 (mean ± SD) 3.97 ± 1.58 4.06 ± 1.49 4.21 ± 1.52 4.07 ± 1.53 0.298
  1. SD standard deviation, CVD cardiovascular disease, DAS28 disease activity score in 28 joint